Combination products are becoming increasingly important in the medical device space. Defined as products composed of any combination of a drug, device, or biological agent, combination products are ...
Read expert advice on how to implement FDA’s rule on current Good Manufacturing Practices for combination products. Mary C. Getz, PhD, Olivia Wong, D. Michelle Garrett, and W. Ben Shand In January ...
This three-day introductory workshop provides a practical foundation for understanding the regulatory landscape governing combination products in the US, European Union, and key global markets.
The new Quality Management System Regulation (QMSR) that became effective on February 2, 2026, includes significant changes in the regulatory framework for combination drug-device and biologic-device ...
The U.S. Food and Drug Administration (FDA) recently finalized its guidance entitled “Requesting Food and Drug Administration Feedback on Combination Products,” stressing as it did in the draft ...
The US Food and Drug Administration (FDA) has released a finalized list of alternatives and streamlined mechanisms for current good manufacturing practice (CGMP) of combination products. During the ...
Seasoned drug delivery and product development leader formerly at Lilly and AstraZeneca to advance Micron Biomedical's transition from platform technology to commercial product company ...
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Drug Device Combination Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Developing a drug delivery device system (combination product) adds a layer of complexity to your pharmaceutical program that many companies underestimate until it's too late. Success depends not just ...
Every year, it is amazing to see how products, from as complicated as automobiles to as simple as cookies, offer new improvements to encourage consumers to upgrade to the “latest and greatest.” Just ...
A new combination product comprising the triptan rizatriptan and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam has shown promising results in the treatment of migraine. In the phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results